The Computer-assisted Drug Design Platform ecosystem spans from upstream data and compound suppliers through midstream software and integration services to downstream pharmaceutical and biotech research teams that apply the solutions. Upstream participants deliver chemical libraries, high‑throughput screening data, and computational resources that feed algorithmic engines. Midstream actors—software developers, AI model providers, and system integrators—assemble these inputs into end‑to‑end platforms, adding workflow orchestration, licensing, and support layers. Downstream users, primarily R&D divisions in pharma, biotech, and contract research organizations, consume the platforms to accelerate target identification, lead optimization, and pre‑clinical decision making. Value is captured through licensing fees, subscription models, and performance‑linked milestones that reflect the speed and accuracy gains delivered.